CD274 and cancer: Among pathways enriched in upregulated immune‐associated DEGs were several pathways that confer decreased immune function, including PD‐L1 expression and the PD‐1 checkpoint pathway in cancer and primary immunodeficiency (Figure 5F), suggesting that the TME in older patients is more immunosuppressive than in younger patients.